The Venture Codex Logo

The Venture Codex

Overview

Government agency supporting innovation and development of enterprises.

Founded

2003

Deals · 12mo

5

Links

Stage focus

Grant
Seed

Geographic focus

Norway

Sector focus

Consulting
Marketing
Trading Platform

Investment portfolio

  • Noemi Aerospace

    Led · Grant · Jul 2026

    Noemi Aerospace is developing a full-scale electric amphibious aircraft and is focused on completing flight testing of a prototype. The company has secured a combination of public and private funding to support prototype development and flight tests. Innovation Norway provided €3 million ($3.4 million) as part of the funding package. Noemi expects the prototype's first flight by the end of 2027. Beyond the announced public grant, additional private investors contributed to the financing, though their identities and amounts were not disclosed. The company is headquartered in Norway and continues progressing toward certification and flight-test milestones.

  • Newcode.ai

    Participated · Seed · Mar 2026

    Newcode.ai builds legal artificial intelligence orchestration solutions and is headquartered in Norway. The company has positioned itself within the legaltech and e-discovery ecosystem, attracting investors connected to Relativity. In its most recent financing, Newcode.ai raised $13.5 million in a Series A led by OnDean Forward, signaling continued investor interest. The company’s backers include The LegalTech Fund, Rel Labs and Antiportfolio Ventures, among other recurring investors. The article did not provide operational metrics such as revenue, users, or specific product roadmaps.

  • Soolv

    Participated · Seed · Dec 2025

    Soolv is building a recruiting intelligence system designed to help employers fairly and efficiently discover exceptional talent hidden in high-volume applicant pools. The platform ingests résumés, transcripts, interviews, tests and other unstructured sources, then extracts hundreds of structured variables that are correlated with past hiring outcomes. These insights surface patterns human screeners often miss, reducing bias and reliance on gut feelings. Early deployments with leading law, consulting and banking firms report a 90 % reduction in tedious manual screening work while ensuring no strong candidate is overlooked. By automating data extraction and predictive scoring, Soolv aims to give employers a faster, fairer and more data-centric approach to graduate hiring. Fresh pre-seed capital will fund further product development and customer expansion as the company scales its solution.

  • PlayIQ

    Participated · Debt Financing · Oct 2025

    PlayIQ is developing an artificial-intelligence platform that ingests match video and extracts more than 10 million data points from every filmed football game. The resulting analytics deliver tactical insights and real-time statistics designed specifically for coaches, analysts and clubs, differentiating the product from fan-oriented services such as Fotmob. The Bergen-based startup has already piloted the solution with Sportsklubben Brann and won the Demo Day pitch competition earlier this autumn. PlayIQ’s founding team of five, led by CEO John Are Brue, still owns 80 % of the company after the latest financing. The company intends to use the new capital to fund roughly one year of operations, build out its board and consider adding additional resources to accelerate growth. Management is targeting profitability once the current runway is exhausted.

  • Vilje Bionics

    Participated · Grant · Sep 2025

    Oslo-based Vilje Bionics develops an externally mounted robotic arm that detects faint muscular signals and amplifies them with electric motors, enabling users with reduced mobility to move their entire arm. The company claims its device is the only solution that assists shoulder, elbow, and hand movement, while competing products address only elbow and grip. Since inception, Vilje Bionics has secured nearly NOK 60 million in funding to advance its medical-grade hardware. The newly raised capital will finance commercial launches in Norway, Germany, and the United States, taking advantage of Norway’s reimbursement scheme for orthopaedic aids through NAV. Founder Saeid Hosseini states that building world-class medical equipment is capital-intensive but can generate global value. Management is targeting NOK 15–25 million in revenue by 2026 as the product reaches market. No other operating metrics were disclosed.

Insights

Team